Abstract:The innate immune system is an evolutionarily conserved system that senses and defends against infection and irritation. Innate immune signaling is a complex cascade that quickly recognizes infectious threats through multiple germline-encoded cell surface or cytoplasmic receptors and transmits signals for the deployment of proper countermeasures through adaptors, kinases, and transcription factors, resulting in the production of cytokines. As the first response of the innate immune system to pathogenic signals, inflammatory responses must be rapid and specific to establish a physical barrier against the spread of infection and must subsequently be terminated once the pathogens have been cleared. Long-lasting and low-grade chronic inflammation is a distinguishing feature of type 2 diabetes and cardiovascular diseases, which are currently major public health problems. Cardiometabolic stress-induced inflammatory responses activate innate immune signaling, which directly contributes to the development of cardiometabolic diseases. Additionally, although the innate immune elements are highly conserved in higher-order jawed vertebrates, lower-grade jawless vertebrates lack several transcription factors and inflammatory cytokine genes downstream of the Toll-like receptors (TLRs) and retinoic acid-inducible gene-I (RIG-I)-like receptors (RLRs) pathways, suggesting that innate immune signaling components may additionally function in an immune-independent way. Notably, recent studies from our group and others have revealed that innate immune signaling can function as a vital regulator of cardiometabolic homeostasis independent of its immune function. Therefore, further investigation of innate immune signaling in cardiometabolic systems may facilitate the discovery of new strategies to manage the initiation and progression of cardiometabolic disorders, leading to better treatments for these diseases. In this review, we summarize the current progress in innate immune signaling studies and the regulatory function of innate immunity in cardiometabolic diseases. Notably, we highlight the immune-independent effects of innate immune signaling components on the development of cardiometabolic disorders.

Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases.

The multiple roles of interferon regulatory factor family in health and disease

Regulation of type I interferon signaling in immunity and inflammation: A comprehensive review

Transcriptional control of metabolism by interferon regulatory factors

The Role of Interferon Regulatory Factors in Liver Diseases

Regulating IRFs in IFN Driven Disease

Key role of interferon regulatory factor 1 (IRF-1) in regulating liver disease: progress and outlook

Innate Immune Signaling and Its Role in Metabolic and Cardiovascular Diseases.

Interferon Regulatory Factors: A Key to Tumour Immunity

Interferon Regulatory Factor 7 Functions As A Novel Negative Regulator of Pathological Cardiac Hypertrophy

The role of IFI16 in regulating PANoptosis and implication in heart diseases

The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

Interferons and interferon-related pathways in heart disease

Regulation of hypoxia-inducible factor α in inflammation-associated diseases mediated by innate immune cells

Macrophages suppress cardiac reprogramming of fibroblasts in vivo via IFN-mediated intercellular self-stimulating circuit

Progress of the interferon regulatory factors in the development of tumor

Emerging Roles of Macrophages in Heart Failure and Associated Treatment Approaches

The role of the ER stress sensor IRE1 in cardiovascular diseases

Interferon Regulatory Factor 3 Constrains IKKβ/NF-κB Signaling to Alleviate Hepatic Steatosis and Insulin Resistance.

The Transcription Factor Interferon Regulatory Factor‐1 is an Endogenous Mediator of Myocardial Ischemia Reperfusion Injury

Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance